Skip to main content
Explore URMC



20th Annual Asthma and Allergy Update 2015: It Takes a Village to Treat Asthma


November 12, 2015


RIT Inn & Conference Center
5257 West Henrietta Rd.
Henrietta, NY  14467

Course Overview:

This Continuing Medical Education activity provides a forum for primary care physicians, physician assistants, nurse practitioners, nurses, mid-level providers, respiratory therapists, and other health care professionals to discuss the latest treatment modalities in the fields of asthma, allergy and pulmonary care.  Case-based presentations will allow the community attendees an opportunity to seek advice on treatment and management of asthma patients from the large panel of experts within the field of asthma management. Participants will gain insights into difficult case presentations and coordination of care, the latest in asthma research from experts in the field, and will be enabled to bring back demonstrations to their office setting.

According to the National Institute of Health – Department of Health and Human Services, more than 25 million people in the United States suffer from asthma. This number includes an estimated 7 million children. It is the third leading cause of hospitalization among people under 18 years of age in
the United States. Asthma is a long term disease and a serious economic concern in the United States, costing the U.S. about $56 billion each year. Although there is no cure for asthma, there are important strategies and tools health care providers can provide to their patients to help manage their asthma symptoms.  According to the National Center for Environmental Health, teaching patients how to manage their asthma is an essential component of controlling asthma nationwide.

At the local level, asthma continues to be of epidemic proportion in New York State.  According to the New York Department of Health, Public Health Information Group, one in nine children and one in twelve adults suffer from asthma in New York State . Studies have also shown that there is a greater risk of developing asthma in people with allergies  and those who smoke. Understanding the contributing environmental factors and incorporating allergen avoidance strategies in the daily lives of asthmatics significantly improves quality of life and asthma symptom control.

Deciding which treatment options to use can be confusing, especially when dealing with a diversity of patients including children, and people facing additional health complications or co-morbidities. In addition, treatment and management options are constantly evolving; in order for patients to receive the best possible care, it is crucial for health care professionals to stay current on the latest research, trends, diagnostic tests, techniques and treatments available. One example of this is the use of sublingual immunotherapy for the treatment of allergic disease, an option that is widely used in many countries. Some aspects of the treatment, such as dosage, administration and length of treatment are still cause for debate and discussion. In the last few years, there has also been increasing research and evidence linking microbiota in individuals to asthma, or the relationship between gastrointestinal microbiome to immune functions and predisposition to asthma and allergies  . This issue will be the topic of the keynote address by Homer A. Boushey, MD, who will discuss the latest evidence as well as possible treatment options given the link between gastrointestinal predisposition to asthma and allergic disease .

The 2015 Update will focus on the multidisciplinary approach to Asthma management, “It Takes a Village to Treat Asthma”. Research has shown that the employment of mid-level providers - such as respiratory care
therapists - in the primary care setting helps to decrease rescue inhaler use and respiratory system scores .
Additionally, a multidisciplinary team approach to the treatment of asthma care has been shown to reduce length of stay in an emergency department setting. This approach also seeks to take into consideration co-morbidities or links between health conditions such as GERD, laryngeal issues, and dermatologic conditions when considering the cause, consequences and possible treatment options for asthma, allergies and other pulmonary conditions.

In addition to a general update on asthma and allergies, as well as some of the issues mentioned above, topics to be addressed this year include inhalation therapy, and peanut sensitization in asthma, among others.

At the conclusion of this conference, participants should be able to:

  • Describe the concept of asthma phenotypes, including asthma/COPD overlap, and how this is beginning to impact therapy.
  • Describe how the Microbiome relates to asthma and allergic disease.
  • Review differences in available inhaler devices and delivery mechanisms.
  • Identify new options for treating allergic disease, including the use of sublingual immunotherapy.
  • Explain peanut sensitization in asthma.
  • Recognize Pulmonary Rehabilitation at URMC.
  • Explain the evaluation and diagnosis of Paradoxical Vocal Fold Motion Disorder.
  • Identify management strategies for GERD and the relationship with asthma.
  • Identify basic characteristics of cat, mold, dust mite, and dog allergy
  • Recognize the role technology may have in asthma monitoring and self-management.
  • Describe the relationship between rhinosinusitis and asthma.
  • Discuss the role of multidisciplinary ‘it takes a village’ approach to effective management of asthma.



Faculty & Speakers


Certification & Accreditation


Registration Fees


Location & Accommodations


Conference Support


Please contact the Center for Experiential Learning 585-275-7666 with any questions or concerns or require assistance with online registration.